Especially, the m6A “reader” IGF2BP2 gene was predominantly amplified with a frequency of 18% in ovarian cancer and the high amplification rate of IGF2BP2 was also reported in other cancers. This evidence concerns the gene IGF2BP2 and ovarian carcinoma.